Murata, Y <br/><br/>
Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients.  [electronic resource] 

 -  Oncology reports   
 - 1299-304 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1021-335X 
<br/><br/><label>Standard No.: </label>10.3892/or.7.6.1299  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alanine Transaminase--blood<br/>Antineoplastic Agents, Hormonal--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Aspartate Aminotransferases--blood<br/>Body Mass Index<br/>Breast Neoplasms--complications<br/>Breast Neoplasms, Male--complications<br/>Chemical and Drug Induced Liver Injury--diagnosis<br/>Cholesterol--blood<br/>Cyclophosphamide--administration & dosage<br/>Diagnosis, Differential<br/>Doxorubicin--administration & dosage<br/>Fatty Liver--chemically induced<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Tamoxifen--adverse effects<br/>Triglycerides--blood